SAM Holdings 9G2

SGD 0.02 -10.00% 0.00 Updated 29 Oct 2026, 11:58 SGT

Company profile

The business, the people and the ownership behind SAM Holdings.

Investor relations ↗Official company website

Business overview

About the company

Singapore Institute of Advanced Medicine Holdings provides medical diagnostics and specialised treatment using advanced medical technologies. Its activities include developing an ambulatory cancer care platform integrating diagnostic, treatment and supportive care services.

Annual Report 2026 ↗ Reviewed 2026-10-23 · Source dated 2026-10-14. PDF p. 23

Listed security

Company & listing

Full Company Name: SINGAPORE INSTITUTE OF ADVANCED MEDICINE HOLDINGS LTD.
Trading Currency: SGD
Website: www.advancedmedicine.sg
Listing: Listed on 16 February 2024 on CATALIST
ISIN Code: SGXE79544776

Board & management

Leadership

PDF p. 16

Dr Djeng Shih Kien

Executive Director and Chief Executive Officer

Board of Directors and CEO

Yeo Seng Lye Paul

Executive Director and Chief Operating Officer

Board of Directors

Levin Tan Eng Kien*

Non-Executive and Non-Independent Director

Board of Directors

Dato’ Sri Lee Kok Chuan

Non-Executive and Non-Independent Director

Board of Directors

Sumei Shum

Independent Director

Board of Directors

Rose Tan Hoon Hoon**

Independent Director

Board of Directors

Roles listed in Annual Report 2026; current appointments are not independently verified.

Holdings

Ownership

As reported at 2026-09-17 · PDF p. 186

Dr Djeng Shih Kien(1)

Direct interest 92,050,000 shares (5.34%); deemed interest 49,199,794 shares (2.85%)

Substantial shareholders

Caterine Limited (2)

Direct interest nil; deemed interest 229,751,580 shares (13.33%)

Substantial shareholders

Espeetex Sdn. Bhd. (3)

Direct interest nil; deemed interest 350,444,407 shares (20.33%)

Substantial shareholders

Berjaya Leisure (Cayman) Limited (3)

Direct interest nil; deemed interest 209,921,558 shares (12.18%)

Substantial shareholders

Crescendas Land Corporation Pte. Ltd. (4)

Direct interest 174,866,776 shares (10.14%); deemed interest nil

Substantial shareholders

Berjaya Property Berhad (3)

Direct interest nil; deemed interest 209,921,558 shares (12.18%)

Substantial shareholders

Berjaya Group Berhad (3)

Direct interest nil; deemed interest 564,965,965 shares (32.77%)

Substantial shareholders

Berjaya Corporation Berhad (3)

Direct interest nil; deemed interest 564,965,965 shares (32.77%)

Substantial shareholders

Tan Sri Dato’ Seri Vincent Tan Chee Yioun (3)

Direct interest nil; deemed interest 565,365,965 shares (32.79%)

Substantial shareholders

Singapore Capital Incorporation Pte. Ltd. (4)

Direct interest nil; deemed interest 174,866,776 shares (10.14%)

Substantial shareholders

Euphonia Pte. Ltd. (4)

Direct interest nil; deemed interest 174,866,776 shares (10.14%)

Substantial shareholders

Lawrence Leow Chin Hin (4)

Direct interest nil; deemed interest 174,866,776 shares (10.14%)

Substantial shareholders

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-09-17 · PDF p. 185

Registered holder	Interest	Source
UOB KAY HIAN PRIVATE LIMITED	820,189,035 shares (47.57%)	PDF p. 1852026-09-17
CRESCENDAS LAND CORPORATION PTE LTD	174,866,776 shares (10.14%)	PDF p. 1852026-09-17
DJENG SHIH KIEN	92,050,000 shares (5.34%)	PDF p. 1852026-09-17
MOOMOO FINANCIAL SINGAPORE PTE. LTD.	58,112,084 shares (3.37%)	PDF p. 1852026-09-17
DBS NOMINEES (PRIVATE) LIMITED	47,704,348 shares (2.77%)	PDF p. 1852026-09-17
AW TAR CHOON	43,571,914 shares (2.53%)	PDF p. 1852026-09-17
RAFFLES NOMINEES (PTE.) LIMITED	42,900,087 shares (2.49%)	PDF p. 1852026-09-17
ISQUARE PTE. LTD.	33,333,333 shares (1.93%)	PDF p. 1852026-09-17
JOYCE SIM JIAHUI	21,302,400 shares (1.24%)	PDF p. 1852026-09-17
KO SIEW LAN MRS DJENG SIEW LAN	19,775,000 shares (1.15%)	PDF p. 1852026-09-17
PETER TAN SHOU YI	19,600,000 shares (1.14%)	PDF p. 1852026-09-17
HSBC (SINGAPORE) NOMINEES PTE LTD	18,105,700 shares (1.05%)	PDF p. 1852026-09-17
OEI GIOK LIONG	14,999,700 shares (0.87%)	PDF p. 1852026-09-17
TIGER BROKERS (SINGAPORE) PTE. LTD.	14,546,560 shares (0.84%)	PDF p. 1852026-09-17
SOO ENG HIONG	13,043,000 shares (0.76%)	PDF p. 1852026-09-17
PHILLIP SECURITIES PTE LTD	12,367,705 shares (0.72%)	PDF p. 1852026-09-17
UNITED OVERSEAS BANK NOMINEES (PRIVATE) LIMITED	11,419,360 shares (0.66%)	PDF p. 1852026-09-17
KWEK BOON HAN	11,371,450 shares (0.66%)	PDF p. 1852026-09-17
YEO KHEE QUAN	11,182,891 shares (0.65%)	PDF p. 1852026-09-17
LOW MING WAH	11,080,721 shares (0.64%)	PDF p. 1852026-09-17

Group structure

Main operating subsidiaries

Company	Market	Ownership interest
Advanced Medicine Imaging Pte. Ltd. (“AMI”)(1)Group; proportion of ownership interest and voting rights, 2026 (2025: 100)PDF p. 1512026-06-30	100
Advanced Medicine Imaging Pte. Ltd. (“AMI”)(1)Group; proportion of ownership interest and voting rights, 2025PDF p. 1512025-06-30	100
Advanced Medicine Oncology Pte. Ltd.Group; proportion of ownership interest and voting rights, 2026 (2025: 100)PDF p. 1512026-06-30	100
Advanced Medicine Oncology Pte. Ltd.Group; proportion of ownership interest and voting rights, 2025PDF p. 1512025-06-30	100
Advanced Medicine Radiopharmaceutical Pte. Ltd. (“AMR”)(2)Group; proportion of ownership interest and voting rights, 2026 (2025: 100)PDF p. 1512026-06-30	100
Advanced Medicine Radiopharmaceutical Pte. Ltd. (“AMR”)(2)Group; proportion of ownership interest and voting rights, 2025PDF p. 1512025-06-30	100
Berjaya Investment Holdings Pte. Ltd. (“BIH”)(3)Group; proportion of ownership interest and voting rights, 2026 (2025: 100)PDF p. 1512026-06-30	100
Berjaya Investment Holdings Pte. Ltd. (“BIH”)(3)Group; proportion of ownership interest and voting rights, 2025PDF p. 1512025-06-30	100
Asia HealthPartners Pte. Ltd. (“AHP”)(1)Group; proportion of ownership interest and voting rights, 2026 (2025: 100)PDF p. 1522026-06-30	100
Asia HealthPartners Pte. Ltd. (“AHP”)(1)Group; proportion of ownership interest and voting rights, 2025PDF p. 1522025-06-30	100
Proton Therapy Pte. Ltd. (“PTPL”)(1)Group; proportion of ownership interest and voting rights, 2026 (2025: 100)PDF p. 1522026-06-30	100
Proton Therapy Pte. Ltd. (“PTPL”)(1)Group; proportion of ownership interest and voting rights, 2025PDF p. 1522025-06-30	100

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Item	Value	Source
MS SHERMIN THAM WAN YI	Chief Financial Officer (“CFO”)	PDF p. 14
DR KWEK BOON HAN	Chief Medial Officer (“CMO”)	PDF p. 14
Wee Woon Hong, LLB (Hons)	JOINT COMPANY SECRETARIES	PDF p. 16
Lim Si Ning Shanin, LLB (Hons)	JOINT COMPANY SECRETARIES	PDF p. 16

Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

Item	Value	Period / scope	Source
Issued and Fully Paid-Up Capital	S$186,153,765.53	Company · As at 2026-09-17	PDF p. 185
Number of Shares	1,724,092,498 shares	Company · As at 2026-09-17	PDF p. 185
Class of Shares	Ordinary Shares	Company · As at 2026-09-17	PDF p. 185
Voting Rights	1 vote for each ordinary share	Company · As at 2026-09-17	PDF p. 185

Treasury shares

Item	Value	Period / scope	Source
Number of Subsidiary Holdings Held	Nil	Company · As at 2026-09-17	PDF p. 185
Treasury shares	There are no treasury shares held by the Company as at 17 September 2026.	Company · As at 2026-09-17	PDF p. 185

Shareholding distribution

Item	Value	Period / scope	Source
TOTAL	548 holders	Total shareholders · As at 2026-09-17	PDF p. 185
1 – 99	2 holders; 0.36% of holders; 105 shares; 0.00% of shares	Size band 1 – 99 · As at 2026-09-17	PDF p. 185
100 – 1,000	83 holders; 15.15% of holders; 69,700 shares; 0.00% of shares	Size band 100 – 1,000 · As at 2026-09-17	PDF p. 185
1,001 – 10,000	113 holders; 20.62% of holders; 860,880 shares; 0.05% of shares	Size band 1,001 – 10,000 · As at 2026-09-17	PDF p. 185
10,001 – 1,000,000	279 holders; 50.91% of holders; 53,238,405 shares; 3.09% of shares	Size band 10,001 – 1,000,000 · As at 2026-09-17	PDF p. 185
1,000,001 AND ABOVE	71 holders; 12.96% of holders; 1,669,923,408 shares; 96.86% of shares	Size band 1,000,001 and above · As at 2026-09-17	PDF p. 185

Free float

Item	Value	Period / scope	Source
Shareholding held in hands of public	approximately 34.63%	Company · As at 2026-09-17	PDF p. 185
Rule 723 compliance	Rule 723 of the Listing Manual Section B: Rule of Catalist of the Singapore Exchange Securities Trading Limited is complied with	Company · As at 2026-09-17	PDF p. 185

Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

Item	Value	Period / scope	Source
Dr Djeng Shih Kien	S$145,118	Group, FY2026, excluding transactions <$100,000 and shareholders' mandate transactions	PDF p. 83
Dynamic	S$156,493	Group, FY2026, excluding transactions <$100,000 and shareholders' mandate transactions	PDF p. 84
Espeetex Sdn.	S$474,189	Group, FY2026, loans per note (3), excluding mandate transactions	PDF p. 84
Espeetex Sdn.	S$23,378,676	Group, FY2026, Espeetex Loan Conversion per note (4)	PDF p. 84
Total	S$23,852,865	Espeetex Sdn. Bhd., FY2026	PDF p. 84
Medical consultancy fees paid to related parties	1,257,291 $	Group, 2026 (2025: 1,314,614)	PDF p. 172
Drawdown of loans from shareholders	7,200,000 $	Group, 2026 (2025: 12,000,000)	PDF p. 172
Interest expense on loans from shareholders	2,014,854 $	Group, 2026 (2025: 1,127,755)	PDF p. 172
Sublease income from a related party	359,490 $	Group, 2026 (2025: 287,019)	PDF p. 172

Director remuneration

Item	Value	Period / scope	Source
Dr Djeng Shih Kien	282,930 S$	FY2026, band Between S$200,000 – S$299,999; 100% salary	PDF p. 66
Yeo Seng Lye Paul	278,562 S$	FY2026, band Between S$200,000 – S$299,999; 100% salary	PDF p. 66
Dato’ Sri Lee Kok Chuan	40,000 S$	FY2026, Below S$100,000, current director; 100% fee	PDF p. 66
Levin Tan Eng Kien (1)	10,849 S$	FY2026, Below S$100,000, current director; 100% fee	PDF p. 66
Sumei Shum	40,000 S$	FY2026, Below S$100,000, current director; 100% fee	PDF p. 66
Vivienne Cheng Chi Fan (3)	24,548 S$	FY2026, former director; 100% fee	PDF p. 67
Khoo Tiam Hock Vernon (4)	40,000 S$	FY2026, former director; 100% fee	PDF p. 67
Gurdip Singh S/O Boor Singh (5)	40,000 S$	FY2026, former director; 100% fee	PDF p. 67

Employees

Item	Value	Period / scope	Source
Total employees	In FY2026, the Group employed a total of 104 employees2 (FY2025: 105) in Singapore	Group, FY2026 (FY2025: 105)	PDF p. 37

Subsequent events

Item	Value	Period / scope	Source
Loan from a shareholder	In September 2026, the Group entered into an interest-bearing loan agreement of $3,000,000 with a shareholder.	Group, after 30 June 2026	PDF p. 183

Outlook

Item	Value	Period / scope	Source
Outlook	For FY2027 and beyond, our priorities are to increase	CEO message to shareholders	PDF p. 7

Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.

Source: Annual Report 2026 ↗

Corporate information

Registration & contacts

Incorporated In: SINGAPORE
Incorporated On: 24 Nov 2011
Email: [email protected]
Telephone: 65 67087890
Fax: 65 67087897
Registered Office: 1 Biopolis Drive
#02-01 Amnios
Singapore 138622
Secretary: Wee Woon Hong
Lim Si Ning Shanin
Registrar / Transfer Agent: BOARDROOM CORPORATE & ADVISORY SERVICES PTE. LTD.
Registrar Address: 1 Harbourfront Avenue, Keppel Bay Tower, #14-07, Singapore 098632
Auditors: FOO KON TAN LLP
Other Stock Exchange Listings: *SINGAPORE EXCHANGE (CATALIST)
Country: SINGAPORE
Security Type: stocks